Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares. The filing date is March 7, 2025, covering a share purchase executed on March 6, 2025. The transaction was conducted through Citigroup Global Markets Limited as part of GSK's existing share buyback programme.
Key Financial Metrics
The filing details a specific share repurchase event rather than comprehensive financial results. Key metrics for the transaction are as follows:
- Shares Purchased: 707,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,474.00 GBp; highest price paid was 1,507.00 GBp.
- Average Price: Volume-weighted average price paid was 1,488.79 GBp.
- Trading Venue: All purchases occurred on the London Stock Exchange (XLON).
Since the commencement of the current non-discretionary agreement on February 24, 2025, GSK has purchased an aggregate of 6,528,342 ordinary shares.
Material Changes and Capital Structure
Following the March 6, 2025 purchase, the company's capital structure has been updated as follows:
- Treasury Shares: GSK now holds 175,598,645 ordinary shares in treasury.
- Shares in Issue: There are 4,139,578,785 ordinary shares in issue (excluding Treasury shares).
- Voting Rights: The total number of voting rights is 4,139,578,785.
The purchased shares are held as Treasury shares. The filing does not provide data on revenue, profit, cash flow, or debt levels.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, management commentary on operational performance, or specific risk factors beyond the standard cautionary statement regarding forward-looking statements. It references risks described in GSK's Annual Report on Form 20-F for 2023 and Q4 Results for 2024. The transaction was executed pursuant to a non-discretionary agreement announced on February 24, 2025.
Investor Verification Checklist
- Verify the total number of shares purchased under the buyback programme since February 24, 2025 (stated as 6,528,342).
- Confirm the updated number of shares in issue (4,139,578,785) for calculating ownership percentages under Disclosure Guidance and Transparency Rules.
- Review the volume-weighted average price (1,488.79 GBp) against market closing prices for March 6, 2025.
- Check the remaining capacity of the buyback programme, as the filing does not state the total authorized amount or remaining limit.